Alzheimer's disease (AD) is a progressive neurodegenerative disorder and a major
contributor to dementia cases worldwide. AD is clinically characterized by learning, memory …

Alzheimer's disease (AD) is a genetically complex, progressive and irreversible
neurodegenerative disorder of the brain which involves multiple associated etiological …

Alzheimer's disease (AD) is multifactorial with unclear etiopathology. Due to the complexity
of AD, many attempted single therapy treatments, like Aß immunization, have generally …

Alzheimer's disease (AD) is a neurodegenerative disorder which is characterized by β-
amyloid (Aβ) aggregation, τ-hyperphosphorylation, and loss of cholinergic neurons. The …

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease for which there are
limited therapeutic strategies. Protein phosphatase 2A (PP2A) activity is decreased in AD …

Background: Alzheimer's disease (AD) is a multifactorial neurodegenerative disease, and a
drug which targets a single protein would not provide a cure for this disease. Currently …

This study aimed to identify potential anti-Alzheimer's disease (AD) targets and action
mechanisms of Ginkgo Folium (GF) through a network pharmacology approach. Eighty-four …

Accumulation of amyloid beta (Aβ) peptide and hyperphosphorylated tau protein has been
proposed to play roles in neural destruction which induce Alzheimer's disease (AD) …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central
nervous system (CNS) leading to mental deterioration and devastation, and eventually a …

Although few drugs are available today for the management of Alzheimer's disease (AD)
and many plants and their extracts are extensively employed in animals' studies and AD …